BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7573092)

  • 1. The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol.
    Wilder LB; Bachorik PS; Finney CA; Moy TF; Becker DM
    Am J Med; 1995 Oct; 99(4):374-7. PubMed ID: 7573092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-cholesterol analysis during screening: accuracy and reliability.
    Bachorik PS; Cloey TA; Finney CA; Lowry DR; Becker DM
    Ann Intern Med; 1991 May; 114(9):741-7. PubMed ID: 2012356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
    Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
    Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.
    Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M
    Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population.
    Yu HH; Markowitz R; De Ferranti SD; Neufeld EJ; Farrow G; Bernstein HH; Rifai N
    Clin Biochem; 2000 Mar; 33(2):89-95. PubMed ID: 10751585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.
    Miida T; Nishimura K; Hirayama S; Miyamoto Y; Nakamura M; Masuda D; Yamashita S; Ushiyama M; Komori T; Fujita N; Yokoyama S; Teramoto T
    J Atheroscler Thromb; 2017 Jun; 24(6):583-599. PubMed ID: 28321014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.
    Sathiyakumar V; Park J; Golozar A; Lazo M; Quispe R; Guallar E; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jan; 137(1):10-19. PubMed ID: 29038168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening with total cholesterol: determining sensitivity and specificity of the National Cholesterol Education Program's guidelines from a population survey.
    Gelskey DE; Young TK; MacDonald SM
    J Clin Epidemiol; 1994 May; 47(5):547-53. PubMed ID: 7730880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JA; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2002 Oct; 90(7):689-96. PubMed ID: 12356379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.
    Martinez-Hervas S; Real JT; Priego MA; Carratalá A; Sniderman AD; Carmena R; Ascaso JF
    Int J Clin Pract; 2013 Jan; 67(1):81-8. PubMed ID: 23241052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.